tradingkey.logo

IM Cannabis Corp

IMCC
1.280USD
-0.020-1.54%
Handelsschluss 02/02, 16:00ETKurse um 15 Minuten verzögert
6.72MMarktkapitalisierung
VerlustKGV TTM

IM Cannabis Corp

1.280
-0.020-1.54%

mehr Informationen über IM Cannabis Corp Unternehmen

IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.

IM Cannabis Corp Informationen

BörsenkürzelIMCC
Name des UnternehmensIM Cannabis Corp
IPO-datumNov 05, 2019
CEOFisher (Eyal)
Anzahl der mitarbeiter55
WertpapierartOrdinary Share
GeschäftsjahresendeNov 05
AddresseKibbutz Glil Yam
Stadt
BörseNASDAQ OMX - NASDAQ BASIC
LandIsrael
Postleitzahl4690500
Telefon14162564202
Websitehttps://imcannabis.com/
BörsenkürzelIMCC
IPO-datumNov 05, 2019
CEOFisher (Eyal)

Führungskräfte von IM Cannabis Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Oren Shuster
Mr. Oren Shuster
Chief Executive Officer, Director
Chief Executive Officer, Director
898.35K
--
Ms. Einat Zakariya
Ms. Einat Zakariya
Independent Director
Independent Director
10.20K
--
Mr. Richard Balla
Mr. Richard Balla
Chief Executive Officer of Adjupharm
Chief Executive Officer of Adjupharm
625.00
-250.00%
Mr. Moti Marcus
Mr. Moti Marcus
Independent Director
Independent Director
--
--
Mr. Uri Birenberg
Mr. Uri Birenberg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eyal Fisher
Mr. Eyal Fisher
Chief Executive Officer of IMC Holdings and each of the Israeli Subsidiaries
Chief Executive Officer of IMC Holdings and each of the Israeli Subsidiaries
--
--
Mrs. Michal Lebovitz Nissimov
Mrs. Michal Lebovitz Nissimov
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Asaf Yitzhaik
Mr. Asaf Yitzhaik
Director
Director
--
--
Mr. Eliyahu (Eli) Zamir
Mr. Eliyahu (Eli) Zamir
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Oren Shuster
Mr. Oren Shuster
Chief Executive Officer, Director
Chief Executive Officer, Director
898.35K
--
Ms. Einat Zakariya
Ms. Einat Zakariya
Independent Director
Independent Director
10.20K
--
Mr. Richard Balla
Mr. Richard Balla
Chief Executive Officer of Adjupharm
Chief Executive Officer of Adjupharm
625.00
-250.00%
Mr. Moti Marcus
Mr. Moti Marcus
Independent Director
Independent Director
--
--
Mr. Uri Birenberg
Mr. Uri Birenberg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Chairman of the Board
Chairman of the Board
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2022Q1
FY2021
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
Germany
8.77M
63.30%
Israel
5.08M
36.70%
Adjustments
0.00
0.00%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, Feb 1
Aktualisiert: Sun, Feb 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Shuster (Oren)
17.12%
Yorkville Advisors Global, LP.
14.41%
Molho (Ran)
13.45%
Gabay (Rafael)
9.88%
Lustig (Marc)
2.96%
Andere
42.18%
Aktionäre
Aktionäre
Anteil
Shuster (Oren)
17.12%
Yorkville Advisors Global, LP.
14.41%
Molho (Ran)
13.45%
Gabay (Rafael)
9.88%
Lustig (Marc)
2.96%
Andere
42.18%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
44.66%
Investment Advisor/Hedge Fund
14.41%
Investment Advisor
3.61%
Hedge Fund
0.22%
Research Firm
0.04%
Andere
37.06%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
31
964.07K
18.37%
+604.99K
2025Q3
33
240.32K
4.58%
-22.41K
2025Q2
38
2.47M
48.05%
+959.10K
2025Q1
38
1.47M
47.74%
-160.92K
2024Q4
42
1.47M
47.79%
+350.95K
2024Q3
48
940.41K
38.51%
-167.62K
2024Q2
52
942.46K
38.60%
-171.69K
2024Q1
56
979.54K
40.26%
-121.50K
2023Q4
56
985.22K
44.75%
-141.95K
2023Q3
65
1.02M
46.98%
-107.12K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Shuster (Oren)
898.35K
17.12%
--
--
Aug 14, 2025
Yorkville Advisors Global, LP.
756.03K
14.41%
+756.03K
--
Sep 30, 2025
Molho (Ran)
705.67K
13.45%
+705.67K
--
Jun 24, 2025
Gabay (Rafael)
518.52K
9.88%
--
--
Aug 14, 2025
Lustig (Marc)
155.11K
2.96%
+8.23K
+5.61%
Dec 31, 2024
AdvisorShares Investments, LLC
104.88K
2%
--
--
Sep 30, 2025
Heron Bay Capital Management, LLC
58.15K
1.11%
-20.64K
-26.19%
Sep 30, 2025
Arbel (Shmulik)
54.86K
1.05%
--
--
Mar 31, 2025
Hidden Cove Wealth Management, LLC
14.29K
0.27%
+14.29K
--
Sep 30, 2025
BMO Nesbitt Burns Inc.
12.18K
0.23%
--
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
AdvisorShares Pure Cannabis ETF
0.33%
Amplify Seymour Cannabis ETF
0%
AdvisorShares Pure Cannabis ETF
Anteil0.33%
Amplify Seymour Cannabis ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
Datum
Ex-Dividendentag
Art
Verhältnis
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Jul 09, 2024
Merger
6→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
Nov 15, 2022
Merger
10→1
KeyAI